Frederick, MD, United States of America

Charles B Millard

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Edgewood, MD (US) (1999)
  • Frederick, MD (US) (2005 - 2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Charles B. Millard**

Introduction

Charles B. Millard, an innovative mind based in Frederick, MD, has made significant contributions to the field of biotechnology with a total of six patents to his name. His pioneering work revolves around developing novel methods for combating toxins, which hold substantial implications for public health and safety.

Latest Patents

Among his latest inventions, Millard has developed a ricin vaccine and associated methods, which involve the use of ricin toxin A chain polypeptides. These engineered polypeptides incorporate a disulfide bond, enabling them to retain immunological epitopes found in wild-type RTA, while displaying enhanced solubility and thermal stability. Significantly, these inventions aim to reduce the risks associated with ricin intoxication through effective immunization strategies. Additionally, his work includes small-molecule botulinum toxin inhibitors, targeting various forms of the botulinum toxin. These innovative inhibitors present methods for using them in therapeutic applications, marking pivotal advancements in toxin management.

Career Highlights

Millard's illustrious career has included pivotal roles at organizations such as the United States Army and the Mayo Foundation for Medical Education and Research. His dedication to research in toxin mitigation has positioned him as an influential inventor in the realm of medical biotechnology.

Collaborations

Throughout his career, Charles B. Millard has collaborated with notable coworkers, including Mark A. Olson and Michael P. Byrne. These partnerships have fostered a collaborative environment that encourages groundbreaking research and innovation in the field.

Conclusion

Charles B. Millard exemplifies the spirit of innovation through his work on significant patents that address critical health concerns related to toxin exposure. His contributions continue to impact the biomedical field, offering promising solutions for preventing and treating intoxication caused by harmful substances.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…